Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected

Trial Profile

Phase 1 Dose Escalation Study to Establish the Safety of Leukocyte Interleukin, Injection for Treatment of Perianal Warts in Adult Men and Women Who Are HIV/HPV Co-infected

Recruiting
Phase of Trial: Phase I

Latest Information Update: 22 Jul 2017

At a glance

  • Drugs Buffy coat interleukins (Primary)
  • Indications Condylomata acuminata
  • Focus Therapeutic Use
  • Sponsors CEL-SCI Corporation
  • Most Recent Events

    • 18 Jul 2017 Planned End Date changed from 1 Sep 2017 to 1 Sep 2018.
    • 18 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
    • 08 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top